Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Alessandra Ambruosia, Svetlana Gelperinab, Alexander Khalanskyc, Sandra Tanskid, Alf Theisend & Jörg Kreuteraa Institute of Pharmaceutical Technology, Johann Wolfgang Goethe-University, Frankfurt am Main, Germanyb Research Center for Molecular Diagnostics and Therapy, Moscow, Russiac Institute of Human Morphology, Moscow, Russiad Zentrale Forschungsanstalt, J. W. Goethe-University, Frankfurt, GermanyInstitute of Pharmaceutical Technology, Johann Wolfgang Goethe-University, Marie-Curie-Straße 9, 60439 Frankfurt am Main, Germany, +49-69-79829682, +49-69-79829694 kreuter@em.uni-frankfurt.dePoly(n-butyl cyanoacrylate) nanoparticles coated with polysorbate-80 can enable the transport of bound drugs across the blood–brain barrier (BBB) after i.v. injection. In the present study the influence of different formulation parameters on the anti-tumoural effects of doxorubicin nanoparticles against glioblastoma 101/8 was investigated. The manufacturing parameters of poly(alkyl cyanoacrylate) doxorubicin-loaded nanoparticles were optimized concerning drug loading. The nanoparticles were coated with different surfactants and injected intravenously on days 2, 5 and 8 after intra-cranial implantation of glioblastoma 101/8 to rats. The survival times of all doxorubicin containing preparations, including a doxorubicin solution, increased the survival times significantly compared to untreated tumour-bearing rats. The most pronounced increase in survival was obtained with the poly(n-butyl cyanoacrylate) doxorubicin-loaded nanoparticles coated with polysorbate 80 and 35% of these animals survived for over 180 days (termination of the experiments). The other nanoparticle preparations yielded lower survival times. Poly(n-butyl cyanoacrylate) doxorubicin-loaded nanoparticles coated with polysorbate 80-coated proved to be very efficient against glioblastoma 101/8. The data suggest that the interaction of nanoparticles with the blood after injection as well as the enhanced permeability and retention effect (EPR effect) contributed differently to the anti-tumoural efficacy depending on nanoparticle formulation and surface properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · cited 1×
“According to the proposed mechanism, the coated polymeric particles would mimic lipoprotein particles and could be transported across the BBB by receptormediated endocytosis (Alyautdin et al. 2001; Kreuter 2001; Kreuter et al. 2002).”
BackgroundApolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · cited 1×
“According to the proposed mechanism, the coated polymeric particles would mimic lipoprotein particles and could be transported across the BBB by receptormediated endocytosis (Alyautdin et al. 2001; Kreuter 2001; Kreuter et al. 2002).”
BackgroundSelf-citationDelivery of therapeutic agents to the central nervous system: the problems and the possibilities
Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443 · cited 1×
“Indeed, poloxamine 908-coated poly(hexadecyl cyanoacrylate) nanoparticles failed to deliver these particles to the healthy brain (Calvo et al. 2001).”
BackgroundVascular microenvironment in gliomas
Vajkoczy, P., & Menger, M. D. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_15 · Cited by 62
Cited by
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Self-citationOvercoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
“NPs coated with special surfactants, such as Polysorbate 80 (P80) (5, 34) or Poloxamer 188 (also referred to as Pluronic F68) (5, 35), or with chitosan (36) have also been shown to target the brain after systemic injection, even with an intact BBB, by adhering to and entering endothelial cells of the BBB.”
BackgroundMethodInteraction of Nanoparticles with Cells
Mailänder, V., & Landfester, K. (2009) · Biomacromolecules · doi:10.1021/bm900266r · Cited by 576
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Self-citation
Metadata
- Authors
- Ambruosi, A., Gelperina, S., Khalansky, A., Tanski, S., Theisen, A., & Kreuter, J.
- Venue
- Journal of Microencapsulation
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 23
- Issue
- 5
- Pages
- 582-592
- ISSN
- 0265-2048 (ISSN-L)
- 1464-5246
- OpenAlex
- W2054637029
- Cited by
- 100
- References
- 5
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. https://app.cochat.ai/papers/10.1080/02652040600788080
- The paper
- Ambruosi, A., Gelperina, S., Khalansky, A., Tanski, S., Theisen, A., & Kreuter, J. (2006). Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. Journal of Microencapsulation. https://doi.org/10.1080/02652040600788080
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.